The Home Depot, Inc. (ETR:HDI)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions EUR. Fiscal year is March - February.

Fiscal Year	Current	FY 2025	FY 2024	FY 2023	FY 2022	FY 2021
Period Ending	Aug 1, 2025	Feb 2, 2025	Jan 28, 2024	Jan 29, 2023	Jan 30, 2022	Jan 31, 2021
Market Capitalization	321,985	393,735	325,469	297,332	342,911	240,191
Market Cap Growth	2.72%	20.97%	9.46%	-13.29%	42.77%	7.02%
Enterprise Value	374,456	453,964	368,909	340,860	378,924	261,933
Last Close Price	321.75	392.48	314.65	271.34	296.00	201.78
PE Ratio	24.94	27.64	23.35	18.87	23.29	22.66
PS Ratio	2.24	2.57	2.32	2.05	2.53	2.21
PB Ratio	45.90	61.63	338.71	206.64	-225.68	88.38
P/FCF Ratio	-	25.07	19.70	28.08	27.33	17.80
P/OCF Ratio	-	20.66	16.70	22.09	23.10	15.48
EV/Sales Ratio	2.65	2.96	2.63	2.35	2.80	2.41
EV/EBITDA Ratio	15.54	18.66	16.07	13.70	16.33	15.29
EV/EBIT Ratio	20.03	21.92	18.48	15.39	18.36	17.40
EV/FCF Ratio	27.95	28.90	22.33	32.19	30.20	19.42
Debt / Equity Ratio	7.79	9.50	50.86	32.74	-27.28	13.16
Debt / EBITDA Ratio	2.23	2.29	1.98	1.78	1.69	1.99
Debt / FCF Ratio	4.08	3.86	2.96	4.45	3.30	2.65
Asset Turnover	1.83	1.85	2.00	2.12	2.12	2.17
Inventory Turnover	4.51	4.78	4.43	4.46	5.19	5.60
Quick Ratio	0.23	0.23	0.32	0.26	0.20	0.47
Current Ratio	1.09	1.11	1.35	1.41	1.01	1.23
Return on Equity (ROE)	299.52%	385.37%	1162.16%	-	2050.28%	14061.20%
Return on Assets (ROA)	15.12%	15.58%	17.72%	20.26%	20.22%	18.76%
Return on Capital (ROIC)	21.80%	21.72%	25.37%	30.89%	31.55%	28.21%
Return on Capital Employed (ROCE)	31.90%	31.90%	39.80%	45.10%	53.40%	38.50%
Earnings Yield	4.01%	3.62%	4.28%	5.30%	4.29%	4.41%
FCF Yield	4.16%	3.99%	5.08%	3.56%	3.66%	5.62%
Dividend Yield	2.58%	2.22%	2.49%	2.65%	2.07%	2.51%
Payout Ratio	61.38%	60.31%	55.36%	45.54%	42.51%	50.14%
Buyback Yield / Dilution	0.33%	0.90%	2.24%	3.12%	1.85%	1.73%
Total Shareholder Return	2.90%	3.12%	4.74%	5.76%	3.93%	4.24%

Updated Mar 21, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.